Objective To examine the characteristics and outcomes among patients with high-risk
pulmonary embolism (PE) and malignancy. Patients and Methods The Nationwide …

A substantial proportion of patients with malignancy develop pulmonary embolism (PE),
which significantly worsens the prognosis and ranks as one of the leading causes of …

Background Cancer-associated pulmonary embolism (PE) places a significant burden on
patients and health care systems. Methods A retrospective cross-sectional analysis of the …

BACKGROUND: Incidence of pulmonary embolism (PE) for different cancer types in
oncology outpatients is unknown. The purposes of the current study is to determine the …

Background The incidence of pulmonary embolism has been increasing. It has been
suggested that this may reflect overdiagnosis due to widespread use of computed …

To study whether a diagnosis of cancer affects the clinical presentation and outcomes of
patients with pulmonary embolism (PE). A retrospective analysis was performed of all …

Background This study aimed to investigate the background of patients who presented with
pulmonary embolism (PE) on contrast-enhanced chest computed tomography (CT) and to …

Pulmonary embolism (PE) is a leading cause of morbidity and mortality in patients with
cancer. The clinical presentation and outcomes of PE range from an acute life-threatening …

Background Several advanced treatments of high-risk patients with pulmonary embolism
have been used in recent decades. We assessed the 19-year national trend in mortality of …

This study aimed to compare the clinical burden and healthcare utilization outcomes of
hematologic versus solid malignancies in patients hospitalized with acute pulmonary …